93 related articles for article (PubMed ID: 7032451)
1. Lymphocyte sensitization detected by the macrophage electrophoretic mobility assay in patients with renal cell carcinoma: Theophylline increases the sensitivity of the assay.
Malkovský M; Bubeník J; Malkovská V; Indrová M; Suhajová E; Jakoubková J; Jíra M
Arch Geschwulstforsch; 1981; 51(4):364-70. PubMed ID: 7032451
[TBL] [Abstract][Full Text] [Related]
2. The macrophage electrophoretic mobility assay in patients with renal cell carcinoma.
Malkovský M; Bubeník J; Jakoubková J; Suhajová E; Indrová M; Jandlová T; Símová J
Neoplasma; 1981; 28(2):245-51. PubMed ID: 7254439
[TBL] [Abstract][Full Text] [Related]
3. [Determination of the MSF (macrophage slowing factor) release by phytohemagglutinin using the macrophage electrophoretic mobility test (MEM test). I. Dependency of release on incubation time, phytohemagglutinin and cell concentration].
Metzner G; Jäger L
Acta Biol Med Ger; 1980; 39(2-3):223-7. PubMed ID: 6999821
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte sensitization detected in lymphomatous hamadryas baboons by the macrophage electrophoretic mobility assay.
Malkovský M; Bubeník J; Indzhiya LV; Lapin BA; Yakovleva LA
Folia Biol (Praha); 1980; 26(1):70-3. PubMed ID: 6244991
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of normal mouse lymphocytes immunized in vitro as detected by macrophage electrophoretic mobility (MEM) test.
Nĕmecková S; Bubeník J; Indrová M
Folia Biol (Praha); 1982; 28(4):280-2. PubMed ID: 7141039
[TBL] [Abstract][Full Text] [Related]
6. The macrophage electrophoretic migration (MEM) test for lymphocyte sensitization. A study of the kinetics.
Carnegie PR; Caspary EA; Dickinson JP; Field EJ
Clin Exp Immunol; 1973 May; 14(1):37-45. PubMed ID: 4716103
[TBL] [Abstract][Full Text] [Related]
7. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
Preece AW; Light PA
Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
[TBL] [Abstract][Full Text] [Related]
8. Reactivity of human lymphocytes to teratoma preparations as revealed by the macrophage electrophoretic mobility (MEM) technique.
Irmscher J; Grossmann H; Kotzsch M; Wagner H; Müller M
Arch Geschwulstforsch; 1982; 52(5):349-53. PubMed ID: 7149908
[TBL] [Abstract][Full Text] [Related]
9. [Cytopherometry in neurologic diseases (author's transl)].
Meyer-Rienecker HJ; Jenssen HL; Köhler H; Werner H
Fortschr Neurol Psychiatr Grenzgeb; 1977 Nov; 45(11):615-29. PubMed ID: 336499
[TBL] [Abstract][Full Text] [Related]
10. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
Brossart P; Stuhler G; Flad T; Stevanovic S; Rammensee HG; Kanz L; Brugger W
Cancer Res; 1998 Feb; 58(4):732-6. PubMed ID: 9485028
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):571-6. PubMed ID: 9679930
[TBL] [Abstract][Full Text] [Related]
12. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
13. [Reaction of inhibition of macrophage electrophoretic mobility in differential diagnosis of carcinomas].
Miuller M; Irmsher Iu; Fisher R; Grosmann G
Vopr Onkol; 1976; 22(12):43-50. PubMed ID: 1020256
[TBL] [Abstract][Full Text] [Related]
14. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines.
Mulders P; Tso CL; Gitlitz B; Kaboo R; Hinkel A; Frand S; Kiertscher S; Roth MD; deKernion J; Figlin R; Belldegrun A
Clin Cancer Res; 1999 Feb; 5(2):445-54. PubMed ID: 10037196
[TBL] [Abstract][Full Text] [Related]
15. [The macrophage electrophoretic mobility LAD test--a diagnostic method for multiple sclerosis (author's transl)].
Meyer-Rienecker H; Jenessen HL; Köhler H; Günther JK
J Neurol; 1976 Feb; 211(3):229-40. PubMed ID: 55489
[TBL] [Abstract][Full Text] [Related]
16. Tumor membrane lymphocyte stimulation assay in patients with renal cell carcinoma.
Hemstreet GP; Dawson JR; Seigler HF
Cancer Res; 1978 May; 38(5):1447-56. PubMed ID: 646859
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis.
Mizutani Y; Nakanishi H; Li YN; Matsubara H; Yamamoto K; Sato N; Shiraishi T; Nakamura T; Mikami K; Okihara K; Takaha N; Ukimura O; Kawauchi A; Nonomura N; Bonavida B; Miki T
Int J Oncol; 2007 Apr; 30(4):919-25. PubMed ID: 17332931
[TBL] [Abstract][Full Text] [Related]
18. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
Bukowski RM; Rayman P; Uzzo R; Bloom T; Sandstrom K; Peereboom D; Olencki T; Budd GT; McLain D; Elson P; Novick A; Finke JH
Clin Cancer Res; 1998 Oct; 4(10):2337-47. PubMed ID: 9796963
[TBL] [Abstract][Full Text] [Related]
19. [Production of factors regulating macrophage motility in the early stages of mixed lymphocyte culture].
Suslov AP; Kharkevich DD
Biull Eksp Biol Med; 1981 Apr; 91(4):466-8. PubMed ID: 6455171
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the macrophage electrophoretic mobility test and the leukocyte migration inhibition test in the detection of histocompatibility antigens on tumor cells.
Bubeník J; Cochran AJ; Todd G; Malkovský M; Jandlová T; Suhajová E; Boubelík M
Neoplasma; 1981; 28(2):185-93. PubMed ID: 7019742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]